Clinical Trials Logo

Filter by:
NCT ID: NCT01087411 Withdrawn - Overweight Clinical Trials

Intervention Study to Prevent Obesity in Sedentary 8 Year Old Swedish Children

STOPP-8
Start date: October 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to study whether a targeted intervention can increase physical activity in inactive 8-yr old children and how it affects secondary measures such as metabolic- and cardiovascular risk factors and markers, self-reported quality of life, BMI, body composition and aerobic work-capacity.

NCT ID: NCT01087112 Recruiting - Clinical trials for Mother-child Relationship Disturbances

Mother-Infant Psychoanalysis Project of Stockholm (MIPPS)- Follow-up at 4½ Years

MIPPS-02
Start date: December 2009
Phase: Phase 0
Study type: Interventional

An RCT comparing mother-infant psychoanalytic treatment (MIP) with Child Health Centre care in cases of mother-infant relationship disturbances was performed on 80 cases in Stockholm 2005-2008. The infants were < 18 months at interview #1. At 6 months follow-ups, significant effects were shown in favour of MIP on maternal sensitivity (EAS), depression (EPDS), and relationship qualities PIR-GAS). This study will evaluate effects at a child age of 4½ years; to evaluate the longterm effects of MIP and CHild Health Centre care, and to better validate results on children who now have reached an age where they can participate more actively in evaluations.

NCT ID: NCT01087021 Completed - Clinical trials for Neoplasms, Malignant

Effect of Cabazitaxel on the QTc Interval in Cancer Patients

QT-Cab
Start date: March 2010
Phase: Phase 1
Study type: Interventional

Primary Objective: - To assess the potential effect on QTcF interval (QTc Fridericia) of cabazitaxel in cancer patients Secondary Objectives: - To assess the effects of cabazitaxel on heart rate (HR), QT, QTcB (Bazett's correction), and QTcN (population specific correction) intervals - To assess the clinical safety of cabazitaxel - To assess cabazitaxel plasma concentrations at Cycle 1 at early timepoints (during infusion and up to 5h post end of infusion)

NCT ID: NCT01086189 Completed - Obesity Clinical Trials

Does Green Tea Affect Postprandial Glucose, Insulin and Satiety in Healthy Subjects

Start date: December 2009
Phase: N/A
Study type: Observational

Green tea consumption could lower the risk of type II diabetes, as suggested by epidemiological studies. There is also evidence from intervention studies that green tea can decrease blood glucose levels and contribute to weight loss. The aim with this study is therefore to examine the postprandial effects of green tea on glycemic index, insulin levels and satiety in healthy individuals after the consumption of a meal.

NCT ID: NCT01085890 Completed - Blood Pressure Clinical Trials

Hypertension in Primary Health Care: Lifestyle Change and Blood Pressure Goals

Start date: March 2007
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a program that includes 1) group seminars and 2) follow-up visits with blood pressure measurement and motivational interviewing (MI) that is focused on lifestyle change affect blood pressure.

NCT ID: NCT01085513 Terminated - Clinical trials for Intestinal Abnormalities

Diagnosis of Intestinal Motility by Image Analysis Using Capsule Endoscopy

Start date: February 2009
Phase: N/A
Study type: Interventional

Conventional intestinal manometry is the current gold standard for the evaluation of intestinal motility, and identifies patterns of intestinal dysmotility. However intestinal manometry involves intestinal intubation with consequent discomfort for the patients, and requires considerable technical expertise and knowledge for interpretation of the data. Hence, to date this method has limited indications and is restricted to very few referral centers around the world. A novel method for evaluation of intestinal motility has been developed based on endoluminal image analysis using the endoscopic PillCam capsule, In contrast to manometry, this technique is minimally invasive, the technical aspects are simple, and the analysis is fully automated by a computer program. The technique has been validated in a group of patients with intestinal dysmotility and healthy subjects, and has demonstrated over 90% sensitivity and specificity. This technique needs now to be validated in a large multinational population, to further develop a robust discrimination algorithm for widespread diagnostic application. Furthermore, whereas manometry only recognizes neuropathic, myopathic and obstructive motor patterns, endoluminal image analysis may identify different categories of patients depending on the clinical presentation and the etiologic factors involved. This study is designed to provide evidence that the algorithm, using images created by PillCam SB2 capsules, is at least as good as small bowel manometry in diagnosing severe dysmotility.

NCT ID: NCT01085123 Completed - Migraine Clinical Trials

Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers

Start date: May 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the central 5-HT1B receptor occupancy of ZOMIG® Rapimelt (zolmitriptan) in healthy male volunteers.

NCT ID: NCT01084707 Completed - Tobacco Dependence Clinical Trials

Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.

Start date: January 2009
Phase: N/A
Study type: Interventional

A comparison of three products for oral nicotine replacement with respect to pharmacokinetics after multiple-doses of nicotine.

NCT ID: NCT01084603 Completed - Tobacco Dependence Clinical Trials

Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product

Start date: March 2009
Phase: N/A
Study type: Interventional

A comparison of three products for oral nicotine replacement with respect to pharmacokinetics after single-dose of nicotine.

NCT ID: NCT01084005 Completed - Clinical trials for Diabetes Mellitus, Type 2

Efficacy and Safety of Linagliptin in Elderly Patients With Type 2 Diabetes

Start date: March 2010
Phase: Phase 3
Study type: Interventional

The objective of the current study is to investigate the efficacy, safety and tolerability of linagliptin (5 mg / once daily) compared to placebo given for 24 weeks as add-on therapy to stable treatment in elderly patients with T2DM with insufficient glycaemic control